146 related articles for article (PubMed ID: 24175310)
1. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Kaur K; Kaur G
Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
[TBL] [Abstract][Full Text] [Related]
2. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
[TBL] [Abstract][Full Text] [Related]
3. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
[TBL] [Abstract][Full Text] [Related]
5. Formulation Development and Evaluation of Lyophilized Nasal Inserts for Migraine Treatment.
Harshada SD; Mundada AS
Recent Pat Drug Deliv Formul; 2017; 11(1):42-53. PubMed ID: 28103774
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
Abdou EM; Kandil SM; Miniawy HMFE
Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
[TBL] [Abstract][Full Text] [Related]
7. Intranasal zolmitriptan for the treatment of acute migraine.
Tepper SJ; Chen S; Reidenbach F; Rapoport AM
Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
[TBL] [Abstract][Full Text] [Related]
8. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.
Zhou W; Li J; Birmingham B; Xu H; Lillieborg S; Zhou D; Al-Huniti N
J Clin Pharmacol; 2017 Oct; 57(10):1258-1267. PubMed ID: 28581633
[TBL] [Abstract][Full Text] [Related]
10. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
11. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Shelke S; Shahi S; Jalalpure S; Dhamecha D
J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
Yu C; Gu P; Zhang W; Cai C; He H; Tang X
Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain.
Khan T; Ranjan R; Dogra Y; Pandya SM; Shafi H; Singh SK; Yadav PN; Misra A
Mol Pharm; 2016 Sep; 13(9):3234-40. PubMed ID: 27518323
[TBL] [Abstract][Full Text] [Related]
14. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Pitta SK; Dudhipala N; Narala A; Veerabrahma K
Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
[TBL] [Abstract][Full Text] [Related]
15. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray.
Nguyen J; Lewis H; Queja A; Diep AN; Hochart G; Ameri M
J Pharm Sci; 2018 Aug; 107(8):2192-2197. PubMed ID: 29772224
[TBL] [Abstract][Full Text] [Related]
17. Intranasal zolmitriptan.
Gawel M; Worthington I
Expert Opin Pharmacother; 2005 Jun; 6(6):1019-24. PubMed ID: 15952929
[TBL] [Abstract][Full Text] [Related]
18. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation.
Bayrak Z; Tas C; Tasdemir U; Erol H; Ozkan CK; Savaser A; Ozkan Y
Eur J Pharm Biopharm; 2011 Aug; 78(3):499-505. PubMed ID: 21352916
[TBL] [Abstract][Full Text] [Related]
19. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
Kumar A; Garg T; Sarma GS; Rath G; Goyal AK
Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136
[TBL] [Abstract][Full Text] [Related]
20. Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.
Kaur G; Rana V; Jain S; Tiwary AK
AAPS PharmSciTech; 2010 Mar; 11(1):36-45. PubMed ID: 20017011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
